Sigma aims to distribute COVID-19 vaccine

Australian Financial Review

10 September 2020 - Sigma Healthcare boss Mark Hooper says the pharmacy wholesaler is in early stage talks with the federal government about its role in distributing a COVID-19 vaccine to the public if one is proved to be successful in clinical trials.

Mr Hooper told The Australian Financial Review that, overall, COVID-19 will moderately assist rather hinder the financial performance of the business as it moves into the second half of fiscal 2021.

Read Australian Financial Review article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Australia , Vaccine , Supply , COVID-19